Search Results - "A. Calmy"

Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study by Weber, R, Ruppik, M, Rickenbach, M, Spoerri, A, Furrer, H, Battegay, M, Cavassini, M, Calmy, A, Bernasconi, E, Schmid, P, Flepp, M, Kowalska, J, Ledergerber, B

“…Background Mortality among HIV‐infected persons is decreasing, and causes of death are changing. Classification of deaths is hampered because of low autopsy…”
Get full text

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study by Franceschi, S, Lise, M, Clifford, G M, Rickenbach, M, Levi, F, Maspoli, M, Bouchardy, C, Dehler, S, Jundt, G, Ess, S, Bordoni, A, Konzelmann, I, Frick, H, Dal Maso, L, Elzi, L, Furrer, H, Calmy, A, Cavassini, M, Ledergerber, B, Keiser, O

“…Background: The advent of highly active antiretroviral therapy (HAART) in 1996 led to a decrease in the incidence of Kaposi's sarcoma (KS) and non-Hodgkin's…”
Get full text

Reply to “Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis” by S. Noe, H. Jaeger, E. Wolf by Biver, E., Calmy, A., Meier, C.

Get full text

Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis by Biver, E., Calmy, A., Aubry-Rozier, B., Birkhäuser, M., Bischoff-Ferrari, H. A., Ferrari, S., Frey, D., Kressig, R. W., Lamy, O., Lippuner, K., Suhm, N., Meier, C.

“…Life expectancy of people living with HIV (PLWH) is reaching similar length as in the general population. Accordingly, age-related comorbidities, including…”
Get full text

Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection by Hofmann, Eveline, Surial, Bernard, Boillat-Blanco, Noémie, Günthard, Huldrych F, Stöckle, Marcel, Bernasconi, Enos, Schmid, Patrick, Calmy, Alexandra, Suter-Riniker, Franziska, Rauch, Andri, Wandeler, Gilles, Béguelin, Charles

“…In the Swiss HIV Cohort Study, 61 of 222 (27%) HIV-suppressed persons with chronic hepatitis B virus (HBV) infection had HBV replication after 2 years on…”
Get full text

Triggers of Change in Sexual Behavior Among People With HIV: The Swiss U U Statement and COVID-19 Compared by Hamusonde, Kalongo, Nicca, Dunja, Gnthard, Huldrych F, Stckle, Marcel, Darling, Katharine E A, Calmy, Alexandra, Bernasconi, Enos, Haerry, David, Schmid, Patrick, Kouyos, Roger D, Rauch, Andri, Salazar-Vizcaya, Luisa

“…We assessed changes in sexual behavior among people with human immunodeficiency virus (HIV) over 20 years. Condom use with stable partners steadily declined…”
Get full text

Population pharmacokinetics of dolutegravir: influence of drug–drug interactions in a real-life setting by Barcelo, Catalina, Aouri, Manel, Courlet, Perrine, Guidi, Monia, Braun, Dominique L, Günthard, Huldrych F, Piso, Rein J, Cavassini, Matthias, Buclin, Thierry, Decosterd, Laurent A, Csajka, Chantal

“…Abstract Objectives Dolutegravir is widely prescribed owing to its potent antiviral activity, high genetic barrier and good tolerability. The aim of this study…”
Get full text

High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men by Braun, Dominique L, Hampel, Benjamin, Kouyos, Roger, Nguyen, Huyen, Shah, Cyril, Flepp, Markus, Stöckle, Marcel, Conen, Anna, Béguelin, Charles, Künzler-Heule, Patrizia, Nicca, Dunja, Schmid, Patrick, Delaloye, Julie, Rougemont, Mathieu, Bernasconi, Enos, Rauch, Andri, Günthard, Huldrych F, Böni, Jürg, Fehr, Jan S

“…We treated 122 human immunodeficiency virus/hepatitis C virus-infected individuals with grazoprevir/elbasvir ± ribavirin for 12-16 weeks and achieved a…”
Get full text

Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in Madagascar by Rakotoarivelo, R., Ambrosioni, J., Rasolofo, V., Raberahona, M., Rakotosamimanana, N., Andrianasolo, R., Ramanampamonjy, R., Tiaray, M., Razafimahefa, J., Rakotoson, J., Randria, M., Bonnet, F., Calmy, A.

“…•This study confirmed the feasibility and usefulness of rapid tuberculosis (TB) diagnosis in Madagascar.•Xpert MTB/RIF showed a good performance for all forms…”
Get full text

Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering Approach by Labarile, Marco, Loosli, Tom, Zeeb, Marius, Kusejko, Katharina, Huber, Michael, Hirsch, Hans H, Perreau, Matthieu, Ramette, Alban, Yerly, Sabine, Cavassini, Matthias, Battegay, Manuel, Rauch, Andri, Calmy, Alexandra, Notter, Julia, Bernasconi, Enos, Fux, Christoph, Günthard, Huldrych F, Pasin, Chloé, Kouyos, Roger D

“…Despite effective prevention approaches, ongoing human immunodeficiency virus 1 (HIV-1) transmission remains a public health concern indicating a need for…”
Get full text

Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study by Rosin, C, Elzi, L, Thurnheer, C, Fehr, J, Cavassini, M, Calmy, A, Schmid, P, Bernasconi, E, Battegay, M

“…Objectives Gender‐specific data on the outcome of combination antiretroviral therapy (cART) are a subject of controversy. We aimed to compare treatment…”
Get full text

A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study by Chaudron, Sandra E, Leemann, Christine, Kusejko, Katharina, Nguyen, Huyen, Tschumi, Nadine, Marzel, Alex, Huber, Michael, Böni, Jürg, Perreau, Matthieu, Klimkait, Thomas, Yerly, Sabine, Ramette, Alban, Hirsch, Hans H, Rauch, Andri, Calmy, Alexandra, Vernazza, Pietro, Bernasconi, Enos, Cavassini, Matthias, Metzner, Karin J, Kouyos, Roger D, Günthard, Huldrych F

“…Studying human immunodeficiency virus type 1 (HIV-1) superinfection is important to understand virus transmission, disease progression, and vaccine design. But…”
Get full text

Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004—2011 by Jordan, M. R., Bennett, D. E., Wainberg, M. A., Havlir, D., Hammer, S., Yang, C., Morris, L., Peeters, M., Wensing, A. M., Parkin, N., Nachega, J. B., Phillips, A., De Luca, A., Geng, E., Calmy, A., Raizes, E., Sandstrom, P., Archibald, C. P., Perriëns, J., McClure, C. M., Hong, S. Y., McMahon, J. H., Dedes, N., Sutherland, D., Bertagnolio, S.

“…The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes…”
Get full text

Ageing with HIV: medication use and risk for potential drug-drug interactions by Marzolini, Catia, Back, David, Weber, Rainer, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Bernasconi, Enos, Khoo, Saye, Battegay, Manuel, Elzi, Luigia

“…Objectives To compare the use of co-medication, the potential drug-drug interactions (PDDIs) and the effect on antiretroviral therapy (ART) tolerability and…”
Get full text

Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection by Fitzmaurice, Karen, Hurst, Jacob, Dring, Megan, Rauch, Andri, McLaren, Paul J, Günthard, Huldrych F, Gardiner, Clair, Klenerman, Paul

“…Chronic HCV infection is a leading cause of liver-related morbidity globally. The innate and adaptive immune responses are thought to be important in…”
Get more information

Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores by Dietrich, Léna G, Thorball, Christian W, Ryom, Lene, Burkhalter, Felix, Hasse, Barbara, Thurnheer, Maria Christine, Weisser, Maja, Schmid, Patrick, Bernasconi, Enos, Darling, Kathrine E A, Buvelot, Hélène, Fellay, Jacques, Ledergerber, Bruno, Tarr, Philip E

“…In people with human immunodeficiency virus (PWH), it is unknown whether genetic background associates with rapid progression of kidney dysfunction (ie,…”
Get full text

Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal women by Calmy, A., Chevalley, T., Delhumeau, C., Toutous-Trellu, L., Spycher-Elbes, R., Ratib, O., Zawadynski, S., Rizzoli, R.

“…Summary We evaluated the influence of long-term HIV infection and its treatment on distal tibia and radius microstructure. Premenopausal eumenorrheic…”
Get full text

The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile by Métral, M, Darling, KEA, Locatelli, I, Nadin, I, Santos, G, Brugger, P, Kovari, H, Cusini, A, Gutbrod, K, Tarr, PE, Calmy, A, Lecompte, TD, Assal, F, Monsch, A, Kunze, U, Stoeckle, M, Schwind, M, Schmid, P, Pignatti, R, Di Benedetto, C, Du Pasquier, R, Cavassini, M, Cavassini, Matthias, Du Pasquier, Renaud, Métral, Mélanie, Simioni, Samanta, Brugger, Peter, Gutbrod, Klemens, Monsch, Andreas U., Kunze, Ursi, Schneitter, Marianne, Nadin, Isaure, Früh, Severin, Schwind, Marc, Pignatti, Riccardo, Clarke, Stefanie, Assal, Frédéric, Derfuss, Tobias, von Arx, Sebastian, Eisele, Günter, Sacco, Leonardo, Bertschi, Manuel, Hundsberger, Thomas, Du Pasquier, Renaud, Calmy, Alexandra, Lecompte, Thanh Doco, Hauser, Christoph, Cusini, Alexia, Weber, Rainer, Kovari, Helen, Hasse, Barbara, Tarr, Philip, Stoeckle, Marcel, Fux, Christoph, Bernasconi, Enos, Di Benedetto, Caroline, Bruno, Alessandra, Schmid, Patrick, Darling, Katharine, Cavassini, Matthias, Scherrer, Alexandra, Scherrer, Alexandra, Vallet, Yannick, Alves, Deolinda, Locatelli, Isabella, Decosterd, Laurent, Granziera, Cristina, Krueger, Gunnar, Meuli, Reto, Vargas, Maria

“…Objectives The aim of the study was to examine baseline neurocognitive impairment (NCI) prevalence and factors associated with NCI among patients enrolled in…”
Get full text

Participation, retention and uptake in a multicentre pre‐exposure prophylaxis cohort using online, smartphone‐compatible data collection by Hovaguimian, F, Martin, E, Reinacher, M, Rasi, M, Schmidt, AJ, Bernasconi, E, Boffi El Amari, E, Braun, DL, Calmy, A, Darling, K, Christinet, V, Depmeier, C, Hauser, C, Läuchli, S, Notter, J, Stoeckle, M, Surial, B, Vernazza, P, Bruggmann, P, Tarr, P, Haerry, D, Bize, R, Low, N, Lehner, A, Böni, J, Kouyos, RD, Fehr, JS, Hampel, B

“…Objectives The aim of the study was to assess the feasibility of a national pre‐exposure prophylaxis (PrEP) programme using smartphone‐compatible data…”
Get full text

Stable HIV‐1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study by Sculier, D, Doco‐Lecompte, T, Yerly, S, Metzner, KJ, Decosterd, LA, Calmy, A

“…Objectives Dolutegravir (DTG) is a highly effective integrase inhibitor with a strong genetic resistance barrier and a potential role in simplified HIV…”
Get full text